Hundreds of lawsuits allege that insulin manufacturers and pharmacy benefit managers colluded to raise prices. The ...

State Sen. Darrin Camilleri, D-Trenton, who sponsored the bills, said there’s no one-size fits all solution. The “common ...

Like tens of thousands of Massachusetts residents, community college professor Carolyn McGrath has been paying for medicine ...

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

Dr. Alice Cheng, MD, FRCPC, Endocrinologist, discusses the different types of insulin and their role in the treatment of ...

Trump’s move “actually is a step backward because he is rolling back the steps taken to promote negotiation under Medicare of ...

The 'big three' insulin producers Novo Nordisk, Eli Lilly, and Sanofi are being sued by the state of California for allegedly working together to set artificially inflated prices for their products.

with its attempts to introduce a cap of insulin prices at $35 per month or 25% of an insurance plan’s negotiated price, whichever of the two is lower. The reason a price cap is being targeted is ...

Joshua Jamerson is the The Wall Street Journal's deputy politics editor, based in Washington.

Indiana has formed a commission to consider annexing nearby parts of Illinois. Why does it bother with formalities?

Medtronic (NYSE:MDT) recently announced the FDA approval for its Simplera Sync sensor, enhancing the MiniMed 780G system with ...